1. INTRODUCTION
Screening of microbial natural products continues to represent an important route to the discovery of novel chemicals for the development of new therapeutic agents and for evaluation of the potential of lesser-known and or new bacterial taxa[1]. Among the micro organisms, actinomycetes gain special importance, as they are the most potent source for the production of antibiotics and other bioactive secondary metabolites. The actinomycetes are Gram positive bacteria having high content in their DNA. The name ‘Actinomycetes’ was derived from Greek ‘aktis’ (a ray) and ‘mykes’ (fungus) and given to these organisms form initial observation of their morphology. Actinomycetes were originally considered to be an intermediate group between bacteria and fungi but now are recognized as prokaryotic organisms.